Cargando…
Bergamottin and PAP-1 Induced ACE2 Degradation to Alleviate Infection of SARS-CoV-2
Angiotensin-converting enzyme 2 (ACE2), a functional receptor for SARS-CoV, now appears likely to mediate 2019-nCoV entry into human cells. However, inhibitors such as PAP-1 and bergamottin have been discovered; both of them can preferentially bind to ACE2, prevent RBD Spike S protein from binding t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604380/ https://www.ncbi.nlm.nih.gov/pubmed/36293419 http://dx.doi.org/10.3390/ijms232012565 |
_version_ | 1784817799445610496 |
---|---|
author | Li, Mengjia Zhang, Yongzheng Zeb, Amir Wu, Yang Cheng, Lufeng |
author_facet | Li, Mengjia Zhang, Yongzheng Zeb, Amir Wu, Yang Cheng, Lufeng |
author_sort | Li, Mengjia |
collection | PubMed |
description | Angiotensin-converting enzyme 2 (ACE2), a functional receptor for SARS-CoV, now appears likely to mediate 2019-nCoV entry into human cells. However, inhibitors such as PAP-1 and bergamottin have been discovered; both of them can preferentially bind to ACE2, prevent RBD Spike S protein from binding to ACE2, and reduce the binding sites for RBD Spike S protein. In addition, we investigated the binding energy of PAP-1 and bergamottin with ACE2 through molecular docking with bio-layer interferometry (BLI) and found relatively high binding affinity (KD = 48.5 nM, 53.1 nM) between the PAP-1 and bergamottin groups. In addition, the nanomolar fraction had no effect on growth of the AT-II cell, but 150 µM PAP-1 and 75 µM bergamottin inhibited the proliferation of AT-II cells in vitro by 75% and 68%, respectively. Meanwhile, they significantly reduced ACE2 mRNA and proteins by 67%, 58% and 55%, 41%, respectively. These results indicate that psoralen compounds PAP-1 and bergamottin binding to ACE2 protein could be further developed in the fight against COVID-19 infection during the current pandemic. However, attention should be paid to the damage to human alveolar type II epithelial cells. |
format | Online Article Text |
id | pubmed-9604380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96043802022-10-27 Bergamottin and PAP-1 Induced ACE2 Degradation to Alleviate Infection of SARS-CoV-2 Li, Mengjia Zhang, Yongzheng Zeb, Amir Wu, Yang Cheng, Lufeng Int J Mol Sci Article Angiotensin-converting enzyme 2 (ACE2), a functional receptor for SARS-CoV, now appears likely to mediate 2019-nCoV entry into human cells. However, inhibitors such as PAP-1 and bergamottin have been discovered; both of them can preferentially bind to ACE2, prevent RBD Spike S protein from binding to ACE2, and reduce the binding sites for RBD Spike S protein. In addition, we investigated the binding energy of PAP-1 and bergamottin with ACE2 through molecular docking with bio-layer interferometry (BLI) and found relatively high binding affinity (KD = 48.5 nM, 53.1 nM) between the PAP-1 and bergamottin groups. In addition, the nanomolar fraction had no effect on growth of the AT-II cell, but 150 µM PAP-1 and 75 µM bergamottin inhibited the proliferation of AT-II cells in vitro by 75% and 68%, respectively. Meanwhile, they significantly reduced ACE2 mRNA and proteins by 67%, 58% and 55%, 41%, respectively. These results indicate that psoralen compounds PAP-1 and bergamottin binding to ACE2 protein could be further developed in the fight against COVID-19 infection during the current pandemic. However, attention should be paid to the damage to human alveolar type II epithelial cells. MDPI 2022-10-19 /pmc/articles/PMC9604380/ /pubmed/36293419 http://dx.doi.org/10.3390/ijms232012565 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Li, Mengjia Zhang, Yongzheng Zeb, Amir Wu, Yang Cheng, Lufeng Bergamottin and PAP-1 Induced ACE2 Degradation to Alleviate Infection of SARS-CoV-2 |
title | Bergamottin and PAP-1 Induced ACE2 Degradation to Alleviate Infection of SARS-CoV-2 |
title_full | Bergamottin and PAP-1 Induced ACE2 Degradation to Alleviate Infection of SARS-CoV-2 |
title_fullStr | Bergamottin and PAP-1 Induced ACE2 Degradation to Alleviate Infection of SARS-CoV-2 |
title_full_unstemmed | Bergamottin and PAP-1 Induced ACE2 Degradation to Alleviate Infection of SARS-CoV-2 |
title_short | Bergamottin and PAP-1 Induced ACE2 Degradation to Alleviate Infection of SARS-CoV-2 |
title_sort | bergamottin and pap-1 induced ace2 degradation to alleviate infection of sars-cov-2 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604380/ https://www.ncbi.nlm.nih.gov/pubmed/36293419 http://dx.doi.org/10.3390/ijms232012565 |
work_keys_str_mv | AT limengjia bergamottinandpap1inducedace2degradationtoalleviateinfectionofsarscov2 AT zhangyongzheng bergamottinandpap1inducedace2degradationtoalleviateinfectionofsarscov2 AT zebamir bergamottinandpap1inducedace2degradationtoalleviateinfectionofsarscov2 AT wuyang bergamottinandpap1inducedace2degradationtoalleviateinfectionofsarscov2 AT chenglufeng bergamottinandpap1inducedace2degradationtoalleviateinfectionofsarscov2 |